Form 8-K - Current report:
SEC Accession No. 0001437749-25-010190
Filing Date
2025-03-31
Accepted
2025-03-31 16:11:39
Documents
16
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20250330_8k.htm   iXBRL 8-K 26920
2 EXHIBIT 99.1 ex_796728.htm EX-99.1 170676
7 logo01.jpg GRAPHIC 3913
  Complete submission text file 0001437749-25-010190.txt   359179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlph-20250331.xsd EX-101.SCH 3580
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20250331_def.xml EX-101.DEF 11808
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20250331_lab.xml EX-101.LAB 15859
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20250331_pre.xml EX-101.PRE 12023
18 EXTRACTED XBRL INSTANCE DOCUMENT acrx20250330_8k_htm.xml XML 2938
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 25793344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)